🇺🇸 FDA
Patent

US 7785806

Method for determining the immunogenicity of an antigen

granted A61PA61P31/00A61P37/00

Quick answer

US patent 7785806 (Method for determining the immunogenicity of an antigen) held by VaxDesign Corp. expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VaxDesign Corp.
Grant date
Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P31/00, A61P37/00